MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, DMAAU has $242,035,303 in assets. $7,392,169 in debts. $14,887 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
3.02%
Quick Ratio
3.02%
Cash Ratio
3.02%
Debt to Asset Ratio
3.05%
Unit: Dollar
Assets Breakdown
    • Cash and investments held in tru...
    • Cash
Liabilities Breakdown
    • Ordinary shares subject to possi...
    • Accumulated deficit
    • Deferred underwriting fee payabl...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash
-6,137 717 -
Prepaid expenses and other current assets
-6,054 27,479 48,904
Cash
14,887 --822
Total current assets
14,887 12,191 28,196 49,726
Deferred offering costs
---0
Cash and investments held in trust account
242,020,416 239,906,656 237,604,232 235,155,966
Total non-current assets
242,020,416 239,906,656 --
Total assets
242,035,303 239,918,847 237,632,428 235,205,692
Promissory note related party-Related Party
---0
Accounts payable and accrued expenses
238,181 222,184 302,623 147,453
Accrued offering costs
153,988 153,988 153,988 153,988
Promissory note
100,000 ---
Total current liabilities
492,169 376,172 456,611 301,441
Deferred underwriting fee payable
6,900,000 6,900,000 6,900,000 6,900,000
Total non-current liabilities
6,900,000 6,900,000 --
Total liabilities
7,392,169 7,276,172 7,356,611 7,201,441
Ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of 10.52 and 10.43 per share as of march 31, 2026, and december 31, 2025, respectively
242,020,416 239,906,656 237,604,232 235,155,966
Ordinary shares, 0.0001 par value 220,000,000 shares authorized 10,717,143 shares issued and outstanding, excluding 23,000,000 shares subject to redemption as of march 31, 2026 and december 31, 2025, respectively
1,072 1,072 1,052 1,052
Share subscription receivable
--608,822 695,825
Additional paid-in capital
---0
Accumulated deficit
-7,378,354 -7,265,053 -6,720,645 -6,456,942
Total shareholders deficit
-7,377,282 -7,263,981 -7,328,415 -7,151,715
Total liabilities, ordinary shares subject to possible redemption and shareholders deficit
242,035,303 239,918,847 237,632,428 235,205,692
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and investmentsheld in trust account$242,020,416 Cash$14,887 Total non-currentassets$242,020,416 Total current assets$14,887 Total assets$242,035,303 Accumulated deficit-$7,378,354 Total liabilities,ordinary shares subject...$242,035,303 Total shareholdersdeficit-$7,377,282 Ordinary shares, 0.0001par value...$1,072 Ordinary shares subjectto possible...$242,020,416 Total liabilities$7,392,169 Total non-currentliabilities$6,900,000 Total currentliabilities$492,169 Deferred underwritingfee payable$6,900,000 Accounts payable andaccrued expenses$238,181 Accrued offering costs$153,988 Promissory note$100,000

Drugs Made In America Acquisition Corp. (DMAAU)

Drugs Made In America Acquisition Corp. (DMAAU)